You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 13 No. 6, December 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Metachromatic Form of Diffuse Cerebral Sclerosis

V. The Nature and Significance of Low Sulfatase Activity: A Controlled Study of Brain, Liver and Kidney in Four Patients With Metachromatic Leukodystrophy (MLD)

JAMES AUSTIN, MD; DONALD ARMSTRONG, BS; LESLIE SHEARER

Arch Neurol. 1965;13(6):593-614.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

PREVIOUS STUDIES in this series have shown that there is an increase in sulfatides in metachromatic leukodystrophy (MLD).1,10 Sulfatide deposits occur not only in relation to the devastated myelin of the central and peripheral nervous system but also in some systemic organs, notably in the kidney and gallbladder.

One reason for an increase in sulfated molecules might be a genetically-determined deficiency of certain sulfatase enzymes. Our recent studies have shown evidence of low sulfatase activities in MLD.11,13-15 This finding of a sulfatase deficiency in a "model" lipid storage disease has been doubly intriguing. Not only does it raise the possibility of some cause and effect relationship with the sulfatide lipidosis of MLD, but it also serves to focus attention on some critical, if thorny, biomedical problems. These concern the genetic regulation, subcellular location, and the broader metabolic role of the hydrolytic enzyme systems in general. Evidence reviewed . . . [Full Text PDF of this Article]


Author Affiliations

PORTLAND, ORE

From the Division of Neurology, University of Oregon Medical School.


Footnotes

Submitted for publication May 10, 1965; accepted July 13.

Read before the American Neurological Association Meeting, Atlantic City, NJ, June 1964.

Reprint requests to Division of Neurology, University of Oregon Medical School, Portland, Ore 97201 (Dr. Austin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.